Could biological disease modifying anti rheumatic drugs (bDMARDs) and small molecules have a key role in preventing COVID-19 infection?
F. Danzo (Milano, Italy), M. Saad (Milano, Italy), S. O'Donnell (Milano, Italy), D. Spitaleri (Milano, Italy), L. Pelosi (Milano, Italy), A. Casartelli (Milano, Italy), D. Radovanovic (Milano, Italy), P. Sarzi-Puttini (Milano, Italy), P. Santus (Milano, Italy)
Source: International Congress 2022 – COVID basic science
Session: COVID basic science
Session type: Thematic Poster
Number: 4077
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Danzo (Milano, Italy), M. Saad (Milano, Italy), S. O'Donnell (Milano, Italy), D. Spitaleri (Milano, Italy), L. Pelosi (Milano, Italy), A. Casartelli (Milano, Italy), D. Radovanovic (Milano, Italy), P. Sarzi-Puttini (Milano, Italy), P. Santus (Milano, Italy). Could biological disease modifying anti rheumatic drugs (bDMARDs) and small molecules have a key role in preventing COVID-19 infection?. 4077
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|